J. Ritter

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

J. Crues, M. Weisman, D. Furst, 2007, Annals of the rheumatic diseases.

Determining the Role of Natural SARS-CoV-2 Infection in the Death of Ten Domestic Pets

K. McCullough, D. Currie, B. Schroeder, 2021 .

Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients.

M. Beltangady, S. Kelley, M. Rozencweig, 1990, Reviews of infectious diseases.

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.

J. Ritter, C. Mclaren, H. Liebman, 1990, The New England journal of medicine.